1248 related articles for article (PubMed ID: 30571348)
41. Lp-PLA2 inhibition prevents Ang II-induced cardiac inflammation and fibrosis by blocking macrophage NLRP3 inflammasome activation.
Lv SL; Zeng ZF; Gan WQ; Wang WQ; Li TG; Hou YF; Yan Z; Zhang RX; Yang M
Acta Pharmacol Sin; 2021 Dec; 42(12):2016-2032. PubMed ID: 34226664
[TBL] [Abstract][Full Text] [Related]
42. Mitochondrial calpain-1 activates NLRP3 inflammasome by cleaving ATP5A1 and inducing mitochondrial ROS in CVB3-induced myocarditis.
Liu X; Li M; Chen Z; Yu Y; Shi H; Yu Y; Wang Y; Chen R; Ge J
Basic Res Cardiol; 2022 Aug; 117(1):40. PubMed ID: 35997820
[TBL] [Abstract][Full Text] [Related]
43. Autophagy Inhibition Contributes to ROS-Producing NLRP3-Dependent Inflammasome Activation and Cytokine Secretion in High Glucose-Induced Macrophages.
Dai J; Zhang X; Li L; Chen H; Chai Y
Cell Physiol Biochem; 2017; 43(1):247-256. PubMed ID: 28854426
[TBL] [Abstract][Full Text] [Related]
44. Microglial activation of the NLRP3 inflammasome by the priming signals derived from macrophages infected with mycobacteria.
Lee HM; Kang J; Lee SJ; Jo EK
Glia; 2013 Mar; 61(3):441-52. PubMed ID: 23280493
[TBL] [Abstract][Full Text] [Related]
45. Elimination of CaMKIIδ Autophosphorylation by CRISPR-Cas9 Base Editing Improves Survival and Cardiac Function in Heart Failure in Mice.
Lebek S; Caravia XM; Chemello F; Tan W; McAnally JR; Chen K; Xu L; Liu N; Bassel-Duby R; Olson EN
Circulation; 2023 Nov; 148(19):1490-1504. PubMed ID: 37712250
[TBL] [Abstract][Full Text] [Related]
46. NLRX1 knockout aggravates lipopolysaccharide (LPS)-induced heart injury and attenuates the anti-LPS cardioprotective effect of CYP2J2/11,12-EET by enhancing activation of NF-κB and NLRP3 inflammasome.
Zhao G; Wang X; Edwards S; Dai M; Li J; Wu L; Xu R; Han J; Yuan H
Eur J Pharmacol; 2020 Aug; 881():173276. PubMed ID: 32574674
[TBL] [Abstract][Full Text] [Related]
47. Soluble uric acid induces myocardial damage through activating the NLRP3 inflammasome.
Zhang H; Ma Y; Cao R; Wang G; Li S; Cao Y; Zhang H; Liu M; Liu G; Zhang J; Li S; Wang Y; Ma Y
J Cell Mol Med; 2020 Aug; 24(15):8849-8861. PubMed ID: 32558367
[TBL] [Abstract][Full Text] [Related]
48. Nuclear Factor E2-Related Factor-2 Negatively Regulates NLRP3 Inflammasome Activity by Inhibiting Reactive Oxygen Species-Induced NLRP3 Priming.
Liu X; Zhang X; Ding Y; Zhou W; Tao L; Lu P; Wang Y; Hu R
Antioxid Redox Signal; 2017 Jan; 26(1):28-43. PubMed ID: 27308893
[TBL] [Abstract][Full Text] [Related]
49. Carbon monoxide releasing molecule-3 improves myocardial function in mice with sepsis by inhibiting NLRP3 inflammasome activation in cardiac fibroblasts.
Zhang W; Tao A; Lan T; Cepinskas G; Kao R; Martin CM; Rui T
Basic Res Cardiol; 2017 Mar; 112(2):16. PubMed ID: 28168403
[TBL] [Abstract][Full Text] [Related]
50. Complement-induced activation of the cardiac NLRP3 inflammasome in sepsis.
Kalbitz M; Fattahi F; Grailer JJ; Jajou L; Malan EA; Zetoune FS; Huber-Lang M; Russell MW; Ward PA
FASEB J; 2016 Dec; 30(12):3997-4006. PubMed ID: 27543123
[TBL] [Abstract][Full Text] [Related]
51. Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome.
Hou L; Yang L; Chang N; Zhao X; Zhou X; Dong C; Liu F; Yang L; Li L
Front Immunol; 2020; 11():1149. PubMed ID: 32695095
[TBL] [Abstract][Full Text] [Related]
52. GEN-27 exhibits anti-inflammatory effects by suppressing the activation of NLRP3 inflammasome and NF-κB pathway.
Hu M; Li X; Zhang J; Yuan Z; Fu Y; Ma X; Ren N
Cell Biol Int; 2019 Oct; 43(10):1184-1192. PubMed ID: 30632647
[TBL] [Abstract][Full Text] [Related]
53. NLRP3 Is a Critical Regulator of Inflammation and Innate Immune Cell Response during Mycoplasma pneumoniae Infection.
Segovia JA; Chang TH; Winter VT; Coalson JJ; Cagle MP; Pandranki L; Bose S; Baseman JB; Kannan TR
Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29061706
[No Abstract] [Full Text] [Related]
54. Ginsenoside Rg3 attenuates angiotensin II-induced myocardial hypertrophy through repressing NLRP3 inflammasome and oxidative stress via modulating SIRT1/NF-κB pathway.
Ren B; Feng J; Yang N; Guo Y; Chen C; Qin Q
Int Immunopharmacol; 2021 Sep; 98():107841. PubMed ID: 34153662
[TBL] [Abstract][Full Text] [Related]
55. CaM Kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia/reperfusion injury.
Weinreuter M; Kreusser MM; Beckendorf J; Schreiter FC; Leuschner F; Lehmann LH; Hofmann KP; Rostosky JS; Diemert N; Xu C; Volz HC; Jungmann A; Nickel A; Sticht C; Gretz N; Maack C; Schneider MD; Gröne HJ; Müller OJ; Katus HA; Backs J
EMBO Mol Med; 2014 Oct; 6(10):1231-45. PubMed ID: 25193973
[TBL] [Abstract][Full Text] [Related]
56. p38δ MAPK: A Novel Regulator of NLRP3 Inflammasome Activation With Increased Expression in Coronary Atherogenesis.
Rajamäki K; Mäyränpää MI; Risco A; Tuimala J; Nurmi K; Cuenda A; Eklund KK; Öörni K; Kovanen PT
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1937-46. PubMed ID: 27417584
[TBL] [Abstract][Full Text] [Related]
57. C-reactive protein overexpression exacerbates pressure overload-induced cardiac remodeling through enhanced inflammatory response.
Nagai T; Anzai T; Kaneko H; Mano Y; Anzai A; Maekawa Y; Takahashi T; Meguro T; Yoshikawa T; Fukuda K
Hypertension; 2011 Feb; 57(2):208-15. PubMed ID: 21220701
[TBL] [Abstract][Full Text] [Related]
58. Cyclooxygenase-2 regulates NLRP3 inflammasome-derived IL-1β production.
Hua KF; Chou JC; Ka SM; Tasi YL; Chen A; Wu SH; Chiu HW; Wong WT; Wang YF; Tsai CL; Ho CL; Lin CH
J Cell Physiol; 2015 Apr; 230(4):863-74. PubMed ID: 25294243
[TBL] [Abstract][Full Text] [Related]
59. TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation.
Malireddi RKS; Gurung P; Mavuluri J; Dasari TK; Klco JM; Chi H; Kanneganti TD
J Exp Med; 2018 Apr; 215(4):1023-1034. PubMed ID: 29500178
[TBL] [Abstract][Full Text] [Related]
60. Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice.
Ling H; Zhang T; Pereira L; Means CK; Cheng H; Gu Y; Dalton ND; Peterson KL; Chen J; Bers D; Brown JH
J Clin Invest; 2009 May; 119(5):1230-40. PubMed ID: 19381018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
